A B Cruz

Universidade Federal de Mato Grosso do Sul, Campo Grande, Estado de Mato Grosso do Sul, Brazil

Are you A B Cruz?

Claim your profile

Publications (11)13.66 Total impact

  • Article: Antifungal activity of fractions and two pure compounds of flowers from Wedelia paludosa (Acmela brasiliensis) (Asteraceae).
    [show abstract] [hide abstract]
    ABSTRACT: Wedelia paludosa (Acmela brasiliensis) (Asteraceae), a traditionally used native Brazilian medicinal plant, showed antifungal activity against dermatophytes in dilution tests. The hexane, dichloromethane and butanol fractions displayed activity against Epidermophyton floccosum, Trichophyton rubrum and Trichophyton mentagrophytes, with minimal inhibitory concentrations between 250 and 1000 microg/mL. Two pure compounds, identified as kaurenoic acid (1) and luteolin (2), also showed activity against these dermatophytes.
    Pharmazie 09/2003; 58(8):567-9. · 1.01 Impact Factor
  • Article: Antibacterial activity of Persea cordata stem barks.
    [show abstract] [hide abstract]
    ABSTRACT: The antibacterial effects of extracts obtained from Persea cordata stem bark, employed in Brazil to treat infectious diseases, were studied. The ethyl acetate fraction of the hydroalcoholic extract showed activity against pathogenic bacteria which may justify the popular use of the plant.
    Fitoterapia 02/2001; 72(1):73-5. · 1.85 Impact Factor
  • Article: Chemical composition and antimicrobial activity of Croton urucurana Baillon (Euphorbiaceae).
    [show abstract] [hide abstract]
    ABSTRACT: In the methanolic extract of Croton urucurana Baillon (Euphorbiaceae) a number of known compounds, such as acetyl aleuritolic acid, stigmasterol, beta-sitosterol, campesterol, beta-sitosterol-O-glucoside, sonderianin, catechin and gallocatechin were isolated and identified by MS and NMR spectroscopy, HRGC and data from literature. The antibacterial activity of the aqueous-EtOH extract, some fractions of the methanolic extract and some of the isolated compounds, were tested against Staphylococcus aureus and Salmonella typhimurium. Acetyl aleuritolic acid exhibits the best minimum inhibitory concentration (MIC) against both Staphylococcus aureus and Salmonella typhimurium.
    Journal of Ethnopharmacology 06/1997; 56(3):223-6. · 3.01 Impact Factor
  • Article: Antibacterial activity and phytochemical analysis of Vochysia divergens (Vochysiaceae).
    [show abstract] [hide abstract]
    ABSTRACT: Vochysia divergens Pohl (Vochysiaceae) is a tree commonly found in wet soils of 'Pantanal' of Mato Grosso, Brazil, and used in folk medicine against infections and asthma. We have studied different extracts and some isolated compounds from this plant for antibacterial activity. From the extracts of the stem bark beta-sitosterol, betulinic acid and sericic acid were isolated. The minimal inhibitory concentration (MIC) for Staphylococcus aureus were: ethanolic extract (MIC = 1.5 mg/ml); ethyl acetate extract (MIC = 2.0 mg/ml); and sericic acid (MIC = 1.0 mg/ml). Escherichia coli was resistant until 5 mg/ml.
    Journal of Ethnopharmacology 08/1995; 47(2):97-100. · 3.01 Impact Factor
  • Article: Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships.
    [show abstract] [hide abstract]
    ABSTRACT: The antibacterial activity of several phyllanthimide analogs were investigated by the Minimum Inhibitory Concentration Method (MIC) against E. coli and S. aureus. It was found that maleimides were approximately 30 times more active than succinimides indicating that the cyclic imido double bond is an important factor related to the activity. Electron-donor and electron-withdrawing substituents in the aromatic ring of N-phenylmaleimides decrease the activity of these compounds indicating the possibility of steric effects. The distance between the aromatic and the imido rings when separated by methylene groups does not affect the antibacterial activity.
    Il Farmaco 11/1994; 49(10):675-7.
  • Article: Differential effects of Mandevilla velutina compounds on paw oedema induced by phospholipase A2 and phospholipase C.
    [show abstract] [hide abstract]
    ABSTRACT: This study compares the effect of Mandevilla velutina compounds with some anti-inflammatory drugs against phospholipase A2- and phospholipase C-induced rat hindpaw oedema. Injection of phospholipase A2 (Naja naja, 2.5-20 U/paw) and phospholipase C (Clostridium perfringens, 0.03-0.05 U/paw) caused a dose-and-time-related increase in paw oedema. Compounds MV 8608 (55 mumol/kg) and MV 8612 (32 mumol/kg, i.p.) inhibited phospholipase A2-induced paw oedema without interfering with phospholipase C-induced oedema. Local injection of both M. velutina compounds also partially attenuated the oedema evoked by phospholipases A2 and C. Dexamethasone (1.3 mumol/kg, p.o.) suppressed only phospholipase A2-induced paw oedema, while indomethacin (11 mumol/kg, p.o.) attenuated only the early phase of phospholipase C-induced oedema. By contrast, phenidone (616 mumol/kg, i.p.) inhibited only phospholipase C-induced oedema, while cyproheptadine (31 mumol/kg) and pyrilamine (100 mumol/kg, p.o.) inhibited only phospholipase A2 oedema. Treatment of animals with compound 48/80 markedly suppressed phospholipase A2-induced paw oedema and to a lesser degree the oedema caused by phospholipase C. Our results indicate that there are marked differences regarding the mechanisms underlying the paw oedema responses caused by phospholipase A2 and phospholipase C. In addition, our data show that M. velutina compounds cause potent and long-lasting inhibition of the pro-inflammatory action of phospholipase A2, an effect which may account for their reported anti-inflammatory activities.
    European Journal of Pharmacology 11/1993; 243(3):213-9. · 2.52 Impact Factor
  • Article: Effect of compounds from Mandevilla velutina on bradykinin-mediated contractile and relaxant responses of the isolated guinea pig trachea.
    [show abstract] [hide abstract]
    ABSTRACT: This study examines the action of three putative functional bradykinin (BK) antagonists isolated from Mandevilla velutina on BK and other agonist-induced contraction or relaxation responses in intact or in epithelium-denuded strips of tracheal muscle from guinea pigs. Compound MV 8612 (8 and 16 microM) and MV 8610 (12 and 24 microM) caused a graded rightward displacement of BK dose-response curves in the isolated guinea pig trachea (dose ratio 2- to 4-fold). Compound MV 8608 (28 microM) had a small effect on BK contractile responses. At high concentrations, compound MV 8612 (24 microM) caused a slight but significant depression of the BK-induced maximal responses. These pharmacological actions appear to be quite selective towards BK, since within the same concentration range these compounds failed to interfere with the sensitivities to prostaglandin F2 alpha, carbachol and histamine. However, these compounds significantly enhanced maximal responses to the latter two agonists, an action that was not influenced by indomethacin. In addition, MV 8612 and MV 8608 (16 and 56 microM) significantly potentiated BK-mediated epithelium-dependent relaxation responses in preparations precontracted with carbachol. These compounds also significantly potentiated isoprenaline but not theophylline-relaxant responses, an action that seems to occur independently of the generation of cyclooxygenase products of arachidonic acid pathway. These results further extend our previous studies and indicate that some of the M. velutina compounds exert a weak though selective antagonistic action against BK-induced contractile responses of the isolated epithelium-denuded guinea pig tracheal smooth muscle and potentiate BK-induced relaxations in tissues with intact epithelium precontracted with carbachol.(ABSTRACT TRUNCATED AT 250 WORDS)
    Agents and Actions 08/1992; 36(3-4):222-9.
  • Article: Extract and compounds obtained from Mandevilla velutina inhibit arachidonic acid-induced ear oedema in mice, but not rat stomach contraction.
    [show abstract] [hide abstract]
    ABSTRACT: This study was designed to analyse the effect of crude extract (CE) and some pure compounds isolated from M. velutina on arachidonic acid (AA)-induced ear oedema in mice. The effect of these compounds on contractions in the rat stomach induced by AA and prostaglandin E2 (PGE2) was also investigated. The CE given orally to mice (50-400 mg/kg) 1h before inhibited the ear oedema in a dose-dependent manner, with a maximal inhibition (MI) of 56%. Given topically, compound MV8612 (200-600 mg/ear) isolated from this plant inhibited the oedema in a concentration-dependent manner with a MI of 66%, while compounds MV8608 and MV8610 (100-600 mg/ear) caused less inhibition, MI 29% and 39% respectively. Compound MV8612, given i.p. (3-30 mg/kg) 30 min before, also caused a dose-dependent inhibition of AA-induced ear oedema (MI of 60.5% compared with 28% and 49% for MV8608 and MV8610). Indomethacin (0.25-1.0 mg/ear) applied topically had no effect, but orally (1-10 mg/kg) gave MI of 66%. Phenidone given orally (10-100 mg/kg) gave a MI of 30% but it was very potent topically (0.5-2 mg/ear) (MI 66%). Nordihydroguaiaretic acid applied either topically (0.5-2.0 mg/ear) or orally (10-100 mg/kg) caused MI of 63% and 47%, respectively. BW 755C, orally (10-100 mg/kg), inhibited the AA-induced oedema in a dose-dependent manner (MI 48%), but was less effective when applied topically (0.25-1 mg/ear) (MI 32%). In the rat stomach preparation, compounds MV8608 and MV8612 (0.1-20 micrograms/ml) had no significant effect on contractions to AA or PGE2, while indomethacin (0.01-3 micrograms/ml) potently inhibited AA contraction, but had no effect on the PGE2 response. These results indicate that MV8608 and MV8612 exhibit both a topical and a systemic anti-inflammatory profile, presumably by a mechanism not related to inhibition of cyclooxygenase.
    Prostaglandins 06/1991; 41(5):515-26.
  • Article: Demonstration of anti-bradykinin compounds in callus cultures of Mandevilla velutina.
    [show abstract] [hide abstract]
    ABSTRACT: Calluses from stems and leaves of Mandevilla velutina were grown in culture for 30, 45 and 60 days. Thin-layer chromatography of ethyl acetate extracts of calluses from stems of M. velutina revealed the presence of 6 compounds. Two of them had RF values identical to those of the anti-bradykinin (BK) compounds MV8609 and MV8610 previously isolated from the natural plant. The ethyl acetate extract (20 to 80 micrograms/ml) from stem callus culture antagonized in a concentration-dependent and reversible manner contractions caused by BK (0.1-1000 nM) in the isolated rat uterus. The extracts obtained from calluses cultured for 30, 45 and 60 days were about 79-, 63- and 31-fold more potent, respectively, in antagonizing BK than the crude extract obtained from the rhizome of the plant.
    Brazilian Journal of Medical and Biological Research 02/1989; 22(10):1275-9. · 1.13 Impact Factor
  • Article: Blockade of the bradykinin-evoked diphasic response of isolated rat duodenum by the crude extract of and compounds obtained from Mandevilla velutina.
    [show abstract] [hide abstract]
    ABSTRACT: The influence of an aqueous/ethanolic extract of M. velutina (CE) and of two compounds (MV 8608 and MV 8612) purified from the plant on BK-, Ad- and K+-induced responses of the rat duodenum was analyzed in vitro. In preparations precontracted with Ca2+, the CE (1 and 2 mg/ml) markedly inhibited BK-induced relaxation in a dose-dependent manner but was less effective against Ad-induced relaxation. The CE (0.5 mg/ml) also antagonized BK-induced relaxation and contraction of strips bathed in normal medium. The two compounds from M. velutina (10 and 20 micrograms/ml) also promoted a dose-dependent blockade of both responses to BK, only slightly depressing the response to K+.
    Brazilian Journal of Medical and Biological Research 02/1988; 21(5):1015-8. · 1.13 Impact Factor
  • Article: Extract and compounds obtained from mandevilla velutina inhibit arachidonic acid-induced ear oedema in mice, but not rat stomach contraction
    [show abstract] [hide abstract]
    ABSTRACT: This study was designed to analyse the effect of crude extract (CE) and some pure compounds isolated from on arachidonic acid (AA)-induced ear oedema in mice. The effect of these compounds on contractions in the rat stomach induced by AA and prostaglandin E2 (PGE2) was also investigated. The CE given orally to mice (50–400 mg/kg) 1 h before inhibited the ear oedema in a dose-dependnt manner, with a maximal inhibition (MI) of 56%. Given topically, compound MV8612 (200–600 mg/ear) isolated from this plant inhibited the oedema in a concentration-dependent manner with a MI of 66%, while compounds MV8608 andMB8610 (100–600 mg/ear) caused less inhibition, MI 29% and 39% respectively. Compound MV8612, given i.p. (3–30 mg/kg) 30 min before, also caused a 60.5% compared with 28% and 49% for MV8608 and MV8610). Indomethacin (0.25–1.0 mg/ear) applied topically had no effect, but orally (1–10 mg/kg) gave MI of 66%. Phenidone given orally (10–100 mg/kg) gave a MI of 30% but it was very potent topically (0.5–2 mg/ear) MI 66%). Nordihydroguaiaretic acid applied either topically (0.5–2.0 mg/ear) or orally (10–100 mg/kg) caused MI of 63% and 47%, respectively. BW 755C, orally (10–100 mg.kg), inhibited the AA-induced oedema in a dose-dependent manner (MI 48%), but was less effective when applied topically (0.25–1 mg/ear) (MI 32%). In the rat stomach preparation, compounds MV8608 and MV8612 (0.1–2.0 μg/ml) had no significant effect on contractiosn to AA of PGE2, while indomethacine (0.01–3 μg/ml) potently inhibited AA contraction, but had no effect on the PGE2 response. These results indicate that MV8608 and MV8612 exhibit both a topical and a systemic anti-inflammatory profile, presumably by a mechanism not related to inhibition of cyclooxygenase.
    Prostaglandins.

Institutions

  • 1995–1997
    • Universidade Federal de Mato Grosso do Sul
      • • Departamento de Biologia (DBI)
      • • Departamento de Ciências do Ambiente (DAM) (CPAN)
      Campo Grande, Estado de Mato Grosso do Sul, Brazil
  • 1988–1992
    • Universidade Federal de Santa Catarina
      • Departamento de Farmacologia
      Florianópolis, Estado de Santa Catarina, Brazil